Trial Profile
PERSONALising Factor VIII prophylaxis regimens: Efficacy of standard versus pharmacokinetically based regimens in adult patients with severe Haemophilia A
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2023
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions
- Acronyms PERSONAL
- 05 Mar 2014 New trial record